This siRNA suppressed the expression of BRAF, harboring the deletion without affecting wild-type BRAF expression in BxPC-3 pancreatic ductal adenocarcinoma cells in vitro and in vivo. This evidence concerns the gene BRAF and pancreatic ductal adenocarcinoma.